Lumosa Therapeutics Co., Ltd. (TPEX:6535)

Taiwan · Delayed Price · Currency is TWD

152.00

+2.00 (1.33%)

Jun 25, 2025, 2:31 PM CST

Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 25.66 billion as of June 25, 2025. Its market cap has decreased by -14.53% in one year.

Market Cap

25.66B

Enterprise Value

24.42B

Revenue

43.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

152.00

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 25.66B, an increase of 497.46%. That is a compound annual growth rate of 19.68%.

Market Cap History

Date	Market Cap	% Change
Jun 24, 2025	25.32B	-40.03%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	191.55B
PharmaEssentia	175.96B
Bora Pharmaceuticals Co., LTD.	83.28B
Lotus Pharmaceutical	55.88B
Oneness Biotech	32.04B
Polaris Group	28.85B
Center Laboratories	26.85B
TaiMed Biologics	26.11B

Market Cap Rankings